NCT06092606 2023-10-23
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Phase 2 Unknown
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Nanfang Hospital, Southern Medical University
Guiyang Medical University